Expert Opinion on Drug Safety
Volume 20, 2021 - Issue 8
Open access
2,655
Views
1
CrossRef citations to date
0
Altmetric
Original research
The long-term safety of chronic azithromycin use in adult patients with cystic fibrosis, evaluating biomarkers for renal function, hepatic function and electrical properties of the heart
A.M. Akkerman-Nijlanda University Medical Center Groningen, Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children’s Hospital, University of Groningen, Groningen, The Netherlands;b Department of Pediatric Pulmonology, University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The NetherlandsCorrespondence[email protected]
View further author information
, View further author information
J.E. Möhlmannc University Medical Center Groningen, Department of Clinical Pharmacy & Pharmacology, University of Groningen, Groningen, The NetherlandsView further author information
, O.W. Akkermand University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, University of Groningen, Groningen, NetherlandsView further author information
, H. Vd Vaartd University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, University of Groningen, Groningen, NetherlandsView further author information
, C.J. Majoore Amsterdam University Medical Centers, Department of Respiratory Medicine, University of Amsterdam, Amsterdam, The NetherlandsView further author information
, B.L. Rottiera University Medical Center Groningen, Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children’s Hospital, University of Groningen, Groningen, The Netherlands;b Department of Pediatric Pulmonology, University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The NetherlandsView further author information
, J.G.M. Burgerhoff University Medical Center Groningen, Department of Epidemiology, University of Groningen, Groningen, The NetherlandsView further author information
, E. Hakf University Medical Center Groningen, Department of Epidemiology, University of Groningen, Groningen, The Netherlands;g Department of Pharmacotherapy, -epidemiology and economics, Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, -epidemiology & -economics, University of Groningen, Groningen, The NetherlandsView further author information
, G.H. Koppelmana University Medical Center Groningen, Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children’s Hospital, University of Groningen, Groningen, The Netherlands;b Department of Pediatric Pulmonology, University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The NetherlandsView further author information
& D.J. Touwc University Medical Center Groningen, Department of Clinical Pharmacy & Pharmacology, University of Groningen, Groningen, The NetherlandsView further author information
show all
Pages 959-963
|
Received 01 Dec 2020, Accepted 18 May 2021, Published online: 07 Jun 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.